anagenics-logoanagenics-logoanagenics-logoanagenics-mobile-24
  • Home
  • About
    • About Anagenics
    • Board of Directors
  • Divisions
    • Our Divisions
    • Beauty
    • Brands
      • évolis®
      • Uspa
  • Investors
    • Investor Centre
    • ASX Announcements
      • 2025
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
    • Financial Information & Reports
    • Share Registry Information
    • Analyst Coverage
    • Share Information
    • Anagenics in the media
    • Newsletter Archive
  • Corporate Governance
    • Corporate Governance
    • Board Charter
    • Code of Conduct
    • Policies
    • Audit Committee Charter
    • Nomination and Remuneration Committee Charter
    • Performance Evaluation Process
    • Corporate Code of Conduct
    • Environmental, Social and Governance Statement
✕

2025 ASX Announcements

  • Home
  • Investor Centre
  • ASX Announcements
  • 2025 ASX Announcements
Date Announcement
28/02/2025 AN1 – 1H25 Update
28/02/2025 Q2 F25 Activity Statement and Appendix 4C
27/02/2025 AN1 – Appendix 4D 1H FY2025
27/02/2025 Anagenics – 1H FY25 Half Year Report
27/02/2025 Notice of General Meeting/Proxy Form
10/02/2025 Update on 2Q25 Activity Report
03/02/2025 Roquefort Therapeutics Announcement
22/01/2025 Long Term Suspended Entities
10/01/2025 Relisting Update
03/01/2025 Roquefort Therapeutics Announcement

Anagenics Limited (ASX: AN1)

Suite 204, Level 2
55 Clarence Street
Sydney NSW 2000
Australia

Today’s Share Price

Careers | Privacy Policy | Contact Us

© 2023 Anagenics Limited. All Rights Reserved. ABN 69 111 304 119.